Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/10778Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bashir, Nadia | - |
| dc.contributor.author | Shah, S W H | - |
| dc.contributor.author | Bangesh, Masroor | - |
| dc.contributor.author | Riazullah | - |
| dc.date.accessioned | 2010-12-27T06:14:35Z | - |
| dc.date.available | 2010-12-27T06:14:35Z | - |
| dc.date.issued | 2011-01 | - |
| dc.identifier.issn | 0975-1084 (Online); 0022-4456 (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/10778 | - |
| dc.description | 51-54 | en_US |
| dc.description.abstract | A simple, sensitive and new spectrophotometric method has been developed for determination of atenolol, a cardiovascular drug. Proposed method is based on deamination of atenolol in basic media, followed by addition of sodium nitroprusside to generate a coloured complex that absorbs at 495 nm. It gave following values: Beer’s law, 0.5-30 µg ml-1; molar absorptivity, 3.01×105 l.mol-1.cm-1; limit of detection, 0.0107 µg ml-1; and limit of quantification, 0.0358 µg ml-1. It was successfully employed for determination of active ingredient concentration in commercial formulations of atenolol. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights | CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | JSIR Vol.70(01) [January 2011] | en_US |
| dc.subject | Atenolol | en_US |
| dc.subject | Deamination | en_US |
| dc.subject | Sodium nitroprusside | en_US |
| dc.subject | Spectrophotometry | en_US |
| dc.title | A novel spectrophotometric determination of atenolol using sodium nitroprusside | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | JSIR Vol.70(01) [January 2011] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| JSIR 70(1) 51-54.pdf | 63.22 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.